China approves Brii Biosciences' COVID-19 treatment – Reuters

China approves Brii Biosciences’ COVID-19 treatment – Reuters

China’s medical products regulator said on Wednesday it has approved the use of BRII Biosciences’ (2137.HK) neutrialising antibody cocktail for COVID-19, the first treatment of its type a…

Read More…